Product Number: RNK35H200

Shipping and Storage

-20℃

Components

Description

This product is a recombinant murine RNase inhibitor expressed and purified in Escherichia coli, with a molecular weight of approximately 50 kD. It can specifically inhibit the activity of RNase A, B, and C,Can form a 1:1 complex with RNase, thereby inhibiting its activity. This reaction is reversible, as urea and thiol reagents can dissociate the complex, causing RNase to be renaturated while inhibitors are irreversibly deactivated. When in use, it can be directly added to the reaction solution containing RNA. This product belongs to protein properties and is different from other competitive inhibitors (nucleic acids, inorganic phosphates). It can be easily removed from the reaction system by phenol treatment.

Compared with human RNase inhibitors, murine RNase inhibitors have higher antioxidant activity and are more suitable for experiments with high DTT sensitivity.

This product does not contain ingredients such as glycerol that affect the freeze-drying process, and can be used for the preparation of freeze-drying reaction systems and product design.

Application

This product can be used in any experiment that requires avoidance of RNase interference to prevent RNA degradation, such as:

1. CDNA synthesis reaction.
2. External translation.
3. Polyribosome separation.
4. There is no cellular system transcription in vitro.

Unit definition

The amount of enzyme required to inhibit 50% of 5ng RNase A activity is defined as one activity unit (U). The activity of RNase A was quantitatively determined by inhibiting the hydrolysis of Cyclic2 ‘, 3’ – CMP to generate 3 ‘- CMP

Quality control

After multiple column purifications, SDS-PAGE gel detection showed only a clear and single target band; The qPCR method detects no residual E. coli DNA and no contamination of nucleic acid endonucleases.

Product Number: RI039

Shipping and Storage

Stored at -20ºC, valid for two years.

Components

Description

RNase Inhibitor, Human Placenta,I.e. Ribonuclease Prohibitor, Human Placenta is a recombinant expression of human placental RNase inhibitor in Escherichia coli, which can bind to RNase A, RNase B, RNase C, and human placental RNase in a non competitive 1:1 ratio and inhibit their activity, thereby protecting RNA from degradation by these enzymes.

RNase inhibitor and Human Placenta have extremely strong inhibitory abilities against RNase A, RNase B, RNase C, and human placental ribonuclease, with Ki values as low as about 4×10^-14M. The affinity constant between antibodies and antigens is usually only 10^–6-10^-9M. And the binding between RNase inhibitor and these RNases is very rapid, almost forming complexes with these RNases at the moment of addition to inhibit their enzymatic activity.

RNase inhibitor and Human Placenta cannot inhibit RNase I T1、T2、H、U1、U2、CL3、RNase from Aspergillus、S1 Nuclease、Taq DNA polymerase,M-MLV reverse transcriptase Enzyme activity of SP6, T7, T3 RNA polymerase.

RNase Inhibitor,Human Placenta maintains its RNAse inhibitory activity within the pH range of 5-8, with the highest inhibitory activity observed at pH 7-8. RNase inhibitor requires at least 1mM DTT in the solution to maintain its activity.

This product has His tag on the N-terminus, and if necessary, RNase inhibitor in the solution will be added after the reaction is complete, Human Placenta can be detected by corresponding His antibodies or removed by magnetic beads or nickel columns adsorption.

This product belongs to the same category as Thermo’s RiboLock RNase Inhibitor and Promega’s RNasin Ribonuclease Inhibitor, both of which are recombinant human placental ribonuclease inhibitors with similar inhibitory effects on RNase (refer to Figure 1 and Figure 2).

Figure 1. RNase inhibitor, Comparison of the inhibitory effects of Human Placenta and competitor RNase inhibitor on RNase A enzyme activity. Incubate 5µg of yeast RNA with 0 or 2ng RNase A and 8, 4, 2, 1, or 0U RNase inhibitor in a 100µl reaction system (50mM MOPS, 5mM MgCl₂, pH 6.5) at 37ºC for 15 minutes. After reaction, take 20µl of reaction solution and use 1% agarose gel for electrophoretic analysis. As shown in the figure, this product has a similar inhibitory effect on RNAse activity compared to Competitor’s product. The experimental results obtained under different experimental conditions may vary slightly during actual operation, and the effects shown in the figure are for reference only.

Figure 2. Comparison of the inhibitory effects of RNase inhibitor, Human Placenta, and competitor RNase inhibitor on RNase A enzyme activity. Incubate 2µg of Hela cell total RNA with 0 or 0.5ng RNase A and 20, 10, 5, 2.5, 1.25, 0.625 or 0U RNase inhibitor in a 20µl reaction system (50mM MOPS, 5mM MgCl₂, pH 6.5) at 37ºC for 15 minutes. Immediately after reaction, all samples were electrophoretically analyzed with 1% agarose gel. As shown in the figure, this product has a similar inhibitory effect on RNAse activity compared to Competitor’s product. The experimental results obtained under different experimental conditions may vary slightly during actual operation, and the results shown in the figure are for reference only.

Source

Expressed by Escherichia coli, the source of the expressed gene is the gene encoding the enzyme in human placenta.

Application

Used for protecting RNA from degradation during processes such as cDNA synthesis, in vitro transcription, in vitro translation, and separation and purification of mRNA protein complexes; It can also be used for the identification of specific RNase activity, etc.

Unit definition

The amount of enzyme that can inhibit 50% of the activity of 5ng RNase A is defined as one activity unit.

Activity detection conditions:

100mM Tris-HCl (pH7.5), 1.2mM EDTA, 0.1mg/ml BSA, 100ng/ml RNase A, 0.1mg/ml E.coli [3H]-RNA, 50mg/ml yeast RNA, 8mM DTT。

Purity

Does not contain DNA endonucleases and exonucleases, and does not contain RNAses.

Storage buffer

20mM HEPES-KOH (pH7.5), 50 mM KCl, 5 mM DTT, 50% (v/v) glycerol。

Inactivation or inhibition

Heating at 75ºC for 10 minutes can result in complete deactivation. Heating at 70ºC for 10 minutes will still result in trace amounts of residual activity. Reagents such as SDS and urea that cause protein denaturation, as well as oxidants such as p-chloromercuribenzoate and potassium dichromate, can inhibit the binding of RNase inhibitor to RNAse.

This product is a GMP grade recombinant RNase inhibitor (RNase inhibitor). When it forms a complex with RNase A in the ratio of 1:1, it has a highly non competitive inhibition on RNase, and the reaction is reversible. In addition, the product could not inhibit the RNase H activity of reverse transcriptase.

This product is a mouse derived recombinant protein RNase inhibitor with a molecular weight of about 50kd. It is expressed on a large scale in yeast and conforms to GMP production and quality management standards. All raw and auxiliary materials are traceable.

Specification

• High purity: ≥ 95%
• Host DNA residue: ≤ 100 pg / mg
• Heavy metal: ≤ 10ppm
• No nonspecific nuclease activity
• Internal toxicity control: ≤ 10 EU / mg
• No RNase activity, endo / exo enzyme activity
• Host protein residue: ≤ 50 ppm
• No virus, mycoplasma and other common pathogens

Order